Global Coronavirus Spike Protein Market Growth 2025-2031

The global Coronavirus Spike Protein market size is predicted to grow from US$ 1481 million in 2025 to US$ 2332 million in 2031; it is expected to grow at a CAGR of 7.9% from 2025 to 2031.

Coronavirus Spike Protein (S Protein) is an important structural protein on the surface of coronaviruses that is responsible for virus binding to and invasion of host cells. The protein initiates the membrane fusion process by binding to the ACE2 receptor on the surface of the host cell, allowing the virus to enter the cell and begin replication. Due to the critical role of the echinocandin protein in the process of viral infection, it has become an important target for vaccines and antibody therapy.

United States market for Coronavirus Spike Protein is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Coronavirus Spike Protein is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Coronavirus Spike Protein is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Coronavirus Spike Protein players cover Abcam, Sanofi, The Native Antigen Company, Bio-Rad Laboratories, Thermo Fisher Scientific, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Coronavirus Spike Protein Industry Forecast” looks at past sales and reviews total world Coronavirus Spike Protein sales in 2024, providing a comprehensive analysis by region and market sector of projected Coronavirus Spike Protein sales for 2025 through 2031. With Coronavirus Spike Protein sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Coronavirus Spike Protein industry.

This Insight Report provides a comprehensive analysis of the global Coronavirus Spike Protein landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Coronavirus Spike Protein portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Coronavirus Spike Protein market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Coronavirus Spike Protein and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Coronavirus Spike Protein.

This report presents a comprehensive overview, market shares, and growth opportunities of Coronavirus Spike Protein market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
90%≤Purity≤95%
Purity＞95%
Other

Segmentation by Application:
RDT & ELISA
Vaccine Development
Antiviral Drugs
Research
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Abcam
Sanofi
The Native Antigen Company
Bio-Rad Laboratories
Thermo Fisher Scientific
Agrisera
Merck KGaA (Sigma-Aldrich)
Seebio
Elabscience
Novus Biologicals
Sinobiological
Eagle Biosciences
BiosPacific

Key Questions Addressed in this Report

What is the 10-year outlook for the global Coronavirus Spike Protein market?

What factors are driving Coronavirus Spike Protein market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Coronavirus Spike Protein market opportunities vary by end market size?

How does Coronavirus Spike Protein break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.